⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2024Frontiers in Public HealthOpen Access

Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises’ R&D investment: a difference-in-differences analysis in China

Jiaming Li Xinyue Zhang Rui Wang Keyao Cao Luhui Wan Ren Xu Jinxi Ding Wei Li

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

This study aimed to evaluate the impact of the National Centralized Drug Procurement (NCDP) policy on chemical pharmaceutical enterprises' R&D investment and provide references for improving NCDP policy design and encouraging innovation in the pharmaceutical industry.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e61f34b6db6435875b0b6f https://doi.org/10.3389/fpubh.2024.1402581

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1The impact of China’s National Drug Centralized Procurement Policy on pharmaceutical firm innovation: evidence from a staggered difference-in-differences analysisOriginal Research · 2026
2Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysisInterrupted Time Series · 2021 · 82 citations
3The impacts of national centralized drug procurement policy on drug utilization of medical institutions: an empirical study in a county-level hospital in China2024 · 16 citations
4The impact of centralized band purchasing of pharmaceuticals on innovation of Chinese pharmaceutical firms: an empirical study based on double difference models2024 · 6 citations
5Effect of centralized volume-based procurement of drugs on business performance of listed pharmaceutical enterprises2024 · 8 citations
6How the Chinese national centralized drug procurement affects the revenues of pharmaceutical companies: a quasi-natural experiment based in China2024 · 1 citations
7National centralized drug procurement and health care expenditure of households—micro-evidence from CFPS2024 · 6 citations
8The impact of the 2019 revision of China’s drug administration law on the innovative output of pharmaceutical and biotechnology enterprises—a quasi-natural experimental study using sharp regression discontinuity designOriginal Research · 2026
9Effectiveness of intervention using artificial intelligence for students with disabilities: systematic review and meta-analysisFrontiers in Public Health · 2026
10Digital health entrepreneurship in Latin America: a systematic review of evidence, challenges, and lessons learnedFrontiers in Public Health · 2026

More from Frontiers in Public Health

More from China Pharmaceutical University

More from Zhejiang Chinese Medical University